Prognostic factors in ductal pancreatic cancer.
Publication/Presentation Date
4-1-1998
Abstract
INTRODUCTION: The diagnosis of pancreatic adenocarcinoma remains a devastating life event for most patients and their families. Many patients with this relatively common malignancy present at a stage of disease not amenable to cancer-directed resectional therapy, and are treated via nonoperative palliative measures, with median survival of 4-8 months post-diagnosis.
CONCLUSION: A minority of patients present with disease limited to the pancreas and periampullary region and are candidates for resectional therapy. The prognosis for these patients is determined by several factors: clinicopathologic staging, tumor biology and molecular genetics, perioperative factors and the use of postoperative adjuvant therapy.
Volume
383
Issue
2
First Page
129
Last Page
133
ISSN
1435-2443
Published In/Presented At
Yeo, C. J., & Cameron, J. L. (1998). Prognostic factors in ductal pancreatic cancer. Langenbeck's archives of surgery, 383(2), 129–133. https://doi.org/10.1007/s004230050104
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
9641885
Department(s)
Administration and Leadership
Document Type
Article